CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)
Close on Nov 18, 2026Market cap $350.75MP/E –Yield –
CorMedix market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
CorMedix's market cap was $411.64M on Nov 11, 2026, against $768.60M a year earlier. Over the last 5 years it ranged from $116.33M to $1.11B, with a median of $288.70M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $411.64M | -54.8% |
| 2025 | Dec 31, 2025 | $911.20M | +94.3% |
| 2024 | Dec 31, 2024 | $468.89M | +127.5% |
| 2023 | Dec 29, 2023 | $206.09M | +18.5% |
| 2022 | Dec 30, 2022 | $173.90M | +0.3% |
| 2021 | Dec 31, 2021 | $173.29M | -25.6% |
| 2020 | Dec 31, 2020 | $232.92M | +24.7% |
| 2019 | Dec 31, 2019 | $186.74M | -70.7% |
| 2018 | Dec 31, 2018 | $637.43M | +311.4% |
| 2017 | Dec 29, 2017 | $154.95M | -49.9% |
| 2016 | Dec 30, 2016 | $309.10M | -13.9% |
| 2015 | Dec 31, 2015 | $359.07M | +68.4% |
| 2014 | Dec 31, 2014 | $213.21M | +115.5% |
| 2013 | Dec 31, 2013 | $98.95M | +140.9% |
| 2012 | Dec 31, 2012 | $41.07M | +157.1% |
| 2011 | Dec 30, 2011 | $15.97M | – |
See a number that looks wrong?